Physician

Ahmad Abdul Karim, M.D

According to 2025 Medicare claims, Ahmad Karim, M.D (NPI: 1588721328) practices cardiac electrophysiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Will, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60435-6654. Karim is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Karim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,749 traditional Medicare patients, billed 10,437 HCPCS/CPT codes, and received $464,004 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,558 prescription claims across 672 beneficiaries totaling $1,127,068 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 11 claims. Open Payments data shows 18 records totaling $563. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $378,466 to $1,127,068. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,649	8,119	$504,260
2016	1,466	6,656	$477,202
2017	1,367	7,616	$489,948
2018	1,355	7,240	$457,935
2019	1,360	7,258	$488,386
2020	1,098	6,886	$466,689
2021	1,280	6,849	$500,599
2022	3,466	10,077	$502,977
2023	3,848	10,953	$486,946
2024	3,749	10,437	$464,004

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	437	3,625	$378,466
2016	462	4,099	$488,022
2017	541	3,363	$552,001
2018	545	2,965	$613,584
2019	555	2,884	$677,135
2020	543	2,704	$769,788
2021	531	2,613	$802,505
2022	554	2,469	$779,943
2023	589	2,921	$866,326
2024	672	3,558	$1,127,068

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	29	$58,386
2017	N/R	11	$23,412
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	432	652	$93
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	377	697	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	538	973	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	553	866	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,785	3,966	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	427	29,046	$553,960
Xarelto	Rivaroxaban	267	20,624	$376,786
Entresto	Sacubitril/Valsartan	51	4,065	$85,573
Multaq	Dronedarone Hcl	16	1,380	$35,645
Flecainide Acetate	Flecainide Acetate	272	23,355	$11,922

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$563	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Abdul Karim, M.D?

Tedicare shows public-source Medicare data for Ahmad Abdul Karim, M.D (NPI 1588721328), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Abdul Karim, M.D have ACO affiliation data?

Ahmad Abdul Karim, M.D is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Ahmad Abdul Karim, M.D?

Ahmad Abdul Karim, M.D is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Ahmad Abdul Karim, M.D have Open Payments data?

Ahmad Abdul Karim, M.D has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.